Cell Culture Market Size To Reach $39.09 Billion By 2030

Cell Culture Market Growth & Trends

The global cell culture market size is expected to reach USD 39.09 billion by 2030 and is expected to grow at a CAGR of 11.32% from 2023 to 2030, according to a new report by Grand View Research, Inc. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).

Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth.Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.

This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention.Furthermore, several companies are engaged in strategic initiatives, such as market expansion, which can be attributed to market growth. For instance, in March 2021, Thermo Fisher Scientific, Inc. announced its expansion plans by investing USD 600 million into capital investments through 2022. Its cell culture media and process liquid sites in Scotland, Florida, and New York increased the production capacity of Gibco cell culture media, process liquids, and supplements. Such developments are expected to propel the market growth over the forecast period.

 Request a free sample copy or view report summary: Cell Culture Market Report

Cell Culture Market Report Highlights

• The consumables product segment accounted for the largest share of 57.44% in 2022 due to increased R&D spending by pharmaceutical & biopharmaceutical businesses to produce advanced biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell & gene therapies

• The biopharmaceutical production segment accounted for the largest share of 32.15% in 2022. The biotechnology sector is anticipated to expand, fueling demand for cell culture supplies and instruments over the forecast period

• North America dominated the market with a share of 35.90% in 2022. The large share can be attributed to the region’s well-established pharmaceutical & biotech sectors and higher adoption of technologically advanced solutions in the U.S. In addition, there is a large market for cell culture technologies in the region due to the extensive cell therapy research efforts undertaken by several universities

• Asia Pacific is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the rising awareness regarding cell and gene therapies, and the rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies

Cell Culture Market Segmentation

Grand view research has segmented the global cell culture market based on product, application, and region:

Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables

  • Sera

    • Fetal Bovine Serum

    • Other

  • Reagents

    • Albumin

    • Others

  • Media

    • Serum-free Media

      • CHO Media

      • HEK 293 Media

      • BHK Medium

      • Vero Medium

      • Other Serum-free Media

    • Classical Media

    • Stem Cell Culture Media

    • Chemically Defined Media

    • Specialty Media

    • Other Cell Culture Media

• Instruments

  • Culture Systems

  • Incubators

  • Centrifuges

  • Cryostorage Equipment

  • Biosafety Equipment

  • Pipetting Instruments

Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production

  • Monoclonal Antibodies

  • Vaccines Production

  • Other Therapeutic Proteins

• Drug Development

• Diagnostics

• Tissue Culture & Engineering

• Cell & Gene Therapy

• Toxicity Testing

• Other Applications

Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Cell Culture Market

• Sartorius AG

• Danaher

• Merck KGaA

• Thermo Fisher Scientific, Inc.

• Corning Inc.

• Avantor, Inc.

• BD

• Eppendorf SE

• Bio-Techne

• PromoCell GmbH